Bronchial Diseases clinical trials
The registry lists 55 studies for Bronchial Diseases across more than 10 countries. 7 are recruiting or about to start. 2 of them are mainly about Bronchial Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-23. Counting its 17 narrower conditions too, such as Carcinoma, Non-Small-Cell Lung: 15,280 studies, 3,049 open.
Get an email when these change. Save the Bronchial Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
AstraZeneca (17) · Novartis Pharmaceuticals (3) · Columbia University (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Upstream Bio Inc. (2) · Assistance Publique - Hôpitaux de Paris (2) · University of Turin, Italy (1) · Altair Therapeutics, Inc. (1)
What is being tested here
Drugs under test in Bronchial Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026AeviceMD for Detection of Wheeze in Pediatric and Adult Populations · Aevice Health Pte. Ltd.
- Sep 2027A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR) · Upstream Bio Inc.
Who these studies take
Of the 6 Bronchial Diseases studies recruiting now, 5 (83%) set no upper age limit and 1 (17%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (17%) | 1 (17%) |
| 18 | 6 (100%) | 6 (100%) |
| 30 | 6 (100%) | 6 (100%) |
| 40 | 6 (100%) | 6 (100%) |
| 50 | 6 (100%) | 6 (100%) |
| 65 | 6 (100%) | 6 (100%) |
| 75 | 6 (100%) | 6 (100%) |
| 85 | 5 (83%) | 5 (83%) |
Across all 55 studies, recruiting or not: 49% stop at 75 or younger and 16% at 65; 22% take children; 2% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Bronchial Diseases studies take
Of 12 phase 3 interventional studies under Bronchial Diseases, half reached primary completion within 26 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 3 | 26 mo10–45 · 12 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 50 of 55. Browse all 55 → or search them.
- BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruitingNCT05341726Not applicable1 country
- Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaRecruitingNCT07120503Phase 28 countries
- Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation RecipientsRecruitingNCT07771855Phase 21 country
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)RecruitingNCT06619561Phase 21 country
- AeviceMD for Detection of Wheeze in Pediatric and Adult PopulationsRecruitingNCT066919711 country
- The Novel Special Light for Endotracheal/Bronchial Lesions.Enrolling by invitationNCT070366141 country
- Patient Reported Outcome and Experience Measures for Bronchoscopic ProceduresRecruitingNCT063073791 country
- Cross-sectional Characterization of Idiopathic BronchiectasisCompletedNCT012640552 countries
- A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With AsthmaCompletedNCT06644924Phase 21 country
- A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)Active, not recruitingNCT06966479Phase 215 countries
- A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)CompletedNCT06196879Phase 215 countries
- A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT04222972Phase 322 countries
- A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic AsthmaTerminatedNCT06592768Phase 11 country
- Individualizing Treatment for Asthma in Primary CareCompletedNCT06272370Phase 41 country
- Indoor Air Quality for Black Adults With Uncontrolled AsthmaCompletedNCT056853811 country
- Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided CryoprobeCompletedNCT05399082Not applicable1 country
- A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy VolunteersCompletedNCT06494345Phase 11 country
- Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)CompletedNCT03186209Phase 34 countries
- Digihaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT05241288Not applicable1 country
- Childhood Asthma Perception StudyCompletedNCT02702687Not applicable1 country
- Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 25 countries
- A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.CompletedNCT03170271Phase 314 countries
- Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and AsthmaCompletedNCT03681093Phase 39 countries
- Systemic Corticosteroids Avoidance Study in Severe Asthma PatientsTerminatedNCT03629249Phase 321 countries
- External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT046974463 countries
- Anti-viral Effects of Azithromycin in Patients With Asthma and COPDStatus unknownNCT04319705Phase 41 country
- Asthma Data Innovation Demonstration ProjectCompletedNCT02162576Not applicable1 country
- A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 AgonistCompletedNCT02808819Phase 315 countries
- Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.CompletedNCT03257995Phase 21 country
- Airway and/or Pulmonary Vessels TransplantationCompletedNCT01331863Phase 1/21 country
- Flexibility and Strength Training in AsthmaCompletedNCT02370004Not applicable1 country
- A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic InflammationCompletedNCT02869438Phase 36 countries
- A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABACompletedNCT02258542Phase 324 countries
- Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCompletedNCT02155660Phase 326 countries
- Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCompletedNCT02138916Phase 317 countries
- A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic SubjectsWithdrawnNCT00830427Phase 2
- Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at HomeCompletedNCT02918071Phase 32 countries
- Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS TherapyCompletedNCT02075255Phase 312 countries
- Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at HomeCompletedNCT02417961Phase 32 countries
- Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent AsthmaCompletedNCT02322775Phase 36 countries
- HFCWO in Hospitalized Asthmatic ChildrenCompletedNCT00722020Not applicable1 country
- Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled AsthmaCompletedNCT01928771Phase 317 countries
- Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 AgonistCompletedNCT01914757Phase 311 countries
- Etiologies, Investigations and Outcomes of Patients Presenting With HemoptysisStatus unknownNCT029133651 country
- Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled AsthmaTerminatedNCT01947946Phase 37 countries
- Efficacy of 3% Hypertonic Saline in Acute Viral BronchiolitisCompletedNCT01777347Phase 31 country
- Safety and Efficacy of WIN-901X in AsthmaCompletedNCT01820481Phase 21 country
- Greatest International Antiinfective Trial With AveloxCompletedNCT0093280224 countries
- Iron Repletion in Chronic Cough and Iron DeficiencyCompletedNCT01507792Not applicable1 country
- Effect of PUR003 on AsthmaCompletedNCT00989521Phase 11 country